McLean Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$250K Buy
8,915
+1,050
+13% +$28K 0.04% 148
2025
Q4
$201K Buy
7,865
+155
+2% +$3.91K 0.04% 171
2025
Q3
$204K Buy
+7,710
New +$190K 0.04% 166
2025
Q2
Sell
-24,770
Closed -$541K 164
2025
Q1
$541K Buy
24,770
+15,972
+182% +$418K 0.18% 70
2024
Q4
$233K Sell
8,798
-312
-3% -$8.46K 0.07% 138
2024
Q3
$260K Buy
9,110
+119
+1% +$3.47K 0.08% 134
2024
Q2
$255K Sell
8,991
-1,203
-12% -$33.1K 0.08% 126
2024
Q1
$273K Sell
10,194
-1,984
-16% -$55.1K 0.09% 119
2023
Q4
$359K Sell
12,178
-593
-5% -$17.9K 0.13% 83
2023
Q3
$424K Sell
12,771
-96
-0.7% -$3.4K 0.17% 69
2023
Q2
$472K Buy
12,867
+114
+0.9% +$4.44K 0.19% 64
2023
Q1
$520K Sell
12,753
-801
-6% -$34.6K 0.21% 56
2022
Q4
$695K Sell
13,554
-33
-0.2% -$1.58K 0.24% 53
2022
Q3
$575K Sell
13,587
-71
-0.5% -$3.45K 0.22% 50
2022
Q2
$720K Buy
13,658
+70
+0.5% +$3.57K 0.29% 40
2022
Q1
$703K Buy
13,588
+7
+0.1% +$363 0.52% 37
2021
Q4
$769K Buy
13,581
+358
+3% +$17.7K 0.3% 38
2021
Q3
$576K Buy
13,223
+2,813
+27% +$125K 0.22% 48
2021
Q2
$420K Buy
10,410
+100
+1% +$3.89K 0.19% 55
2021
Q1
$396K Sell
10,310
-126
-1% -$4.47K 0.31% 53
2020
Q4
$384K Buy
+10,436
New +$383K 0.34% 47

Other funds holding PFE

McLean Asset Management's PFE Position: Q1 2026 in Review

McLean Asset Management increased its Pfizer (PFE) stake by 13% in Q1 2026, buying an estimated $28K and bringing the position to 8,915 shares worth $250K. The position accounts for 0.04% of the portfolio, ranked #148.

McLean Asset Management first reported a position in PFE in Q4 2020 and has held it in 21 quarters since. The position peaked at $769K in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • McLean Asset Management held 8,915 shares of Pfizer worth $250K as of Q1 2026.
  • McLean Asset Management bought 1,050 Pfizer shares in Q1 2026, an estimated $28K.
  • Pfizer made up 0.04% of McLean Asset Management's portfolio in Q1 2026, its #148 holding.
  • McLean Asset Management first reported a position in Pfizer in Q4 2020 and has held it in 21 quarters since.
  • McLean Asset Management's Pfizer position peaked at $769K in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on McLean Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.